Data gathered: February 28
AI Stock Analysis - Edwards Lifesciences (EW)
Analysis generated October 24, 2024. Powered by Chat GPT.
Edwards Lifesciences Corporation is a prominent American medical equipment company. Renowned for its innovative heart valve products, it primarily designs, manufactures, and markets technologies for structural heart disease, especially in relation to critical care and surgical monitoring. The company’s key product lines include transcatheter heart valves, surgical heart valves, and critical care products. With a focus on heart-related medical devices, Edwards Lifesciences serves a critical role in the healthcare sector and sees steady demand for its life-saving technologies.
Stock Alerts - Edwards Lifesciences (EW)
![]() |
Edwards Lifesciences | February 15 Insider Alert: LORANGER STEVEN R is selling shares |
![]() |
Edwards Lifesciences | February 14 Over the past few months, there has been a noticeable upward trend in Job postings. |
![]() |
Edwards Lifesciences | February 14 Insider Alert: Ullem Scott B. is selling shares |
![]() |
Edwards Lifesciences | February 12 Price is up by 5.3% in the last 24h. |
Alternative Data for Edwards Lifesciences
About Edwards Lifesciences
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.

Price | $71.40 |
Target Price | Sign up |
Volume | 2,970,000 |
Market Cap | $42.1B |
Year Range | $59.7 - $93.78 |
Dividend Yield | 0% |
PE Ratio | 30.51 |
Analyst Rating | 45% buy |
Industry | Medical Devices |
In the news
![]() |
Edwards Lifesciences Co. (NYSE:EW) Given Average Rating of “Hold” by BrokeragesFebruary 28 - ETF Daily News |
![]() |
Private Advisor Group LLC Acquires 9,440 Shares of Edwards Lifesciences Co. (NYSE:EW)February 27 - ETF Daily News |
![]() |
A Look Into Edwards Lifesciences Inc's Price Over EarningsFebruary 26 - Biztoc.com |
![]() |
D.A. Davidson & CO. Has $743,000 Stake in Edwards Lifesciences Co. (NYSE:EW)February 25 - ETF Daily News |
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitorsFebruary 25 - MarketWatch |
|
![]() |
Principal Securities Inc. Decreases Stake in Edwards Lifesciences Co. (NYSE:EW)February 25 - ETF Daily News |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q3 '24 | 1.38B | 717M | 1.09B | 3.07B | 429M | 0.670 |
Q2 '24 | 1.4B | 736M | 1.1B | 366M | 417M | 0.700 |
Q1 '24 | 1.61B | 875M | 1.21B | 352M | 399M | 0.660 |
Q4 '23 | 1.49B | 842M | 1.18B | 370M | 459M | 0.640 |
Q3 '23 | 1.5B | 790M | 993M | 385M | 423M | 0.590 |
Insider Transactions View All
LORANGER STEVEN R filed to sell 60,372 shares at $76.4. February 14 '25 |
Lippis Daniel J. filed to sell 23,189 shares at $76.3. February 13 '25 |
BOBO DONALD E JR filed to sell 53,336 shares at $76.3. February 13 '25 |
STONE HEISZ LESLIE filed to sell 30,035 shares at $75.9. February 13 '25 |
BOBO DONALD E JR filed to sell 46,936 shares at $75.7. February 13 '25 |
Similar companies
Company | Price | AI Score | |
---|---|---|---|
![]() |
Boston ScientificBSX |
$100.8 0% | 60 |
![]() |
Intuitive SurgicalISRG |
$563.77 0% | 73 |
![]() |
MedtronicMDT |
$90.74 0% | 44 |
![]() |
StrykerSYK |
$388.9 0% | 57 |
![]() |
Becton Dickinson and CoBDX |
$224.16 0% | 51 |
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Ro Khanna |
Nov 11, 24 | Buy | $1K - $15K |
Ro Khanna |
Oct 8, 24 | Buy | $1K - $15K |
Mike Kelly |
Jun 14, 24 | Sell | $1K - $15K |
Read more about Edwards Lifesciences (EW) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Edwards Lifesciences?
The Market Cap of Edwards Lifesciences is $42.1B.
What is Edwards Lifesciences' PE Ratio?
As of today, Edwards Lifesciences' PE (Price to Earnings) ratio is 30.51.
What is the current stock price of Edwards Lifesciences?
Currently, the price of one share of Edwards Lifesciences stock is $71.40.
How can I analyze the EW stock price chart for investment decisions?
The EW stock price chart above provides a comprehensive visual representation of Edwards Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Edwards Lifesciences shares. Our platform offers an up-to-date EW stock price chart, along with technical data analysis and alternative data insights.
Does EW offer dividends to its shareholders?
As of our latest update, Edwards Lifesciences (EW) does not offer dividends to its shareholders. Investors interested in Edwards Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Edwards Lifesciences?
Some of the similar stocks of Edwards Lifesciences are Boston Scientific, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
.